Skip to main content
Top
Published in: Endocrine 2/2013

01-10-2013 | Meta-Analysis

The CTLA4 +49A/G polymorphism is associated with an increased risk of Hashimoto’s thyroiditis in Asian but not Caucasian populations: an updated meta-analysis

Authors: Ming Feng, Fang-Bin Zhang, Hong-Rong Deng

Published in: Endocrine | Issue 2/2013

Login to get access

Abstract

The polymorphism +49A/G in the cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) gene has been implicated in susceptibility to Hashimoto’s thyroiditis (HT), but the findings are not clear-cut. This study aimed to investigate the association between CTLA-4 polymorphisms and HT risk using an updated meta-analysis. A meta-analysis was carried out of 14 previous studies that investigated the CTLA-4 +49A/G polymorphism and HT risk. +49A/G was associated with a significantly increased HT risk in both allele analysis and all genetic models (allele analysis: G vs. A: P < 0.001, OR = 1.379, 95 % CI = 1.244–1.529). Subgroup analysis by ethnicity showed a significantly increased HT risk with the G allele and all other genetic models in the Asian subgroup (P < 0.001). In the Caucasian subgroup, no significant association was detected between the CTLA-4 +49 G allele and HT, or in the genetic model analysis (P = 0.05). This gene-based analysis indicates that the cumulative effect of the +49A/G polymorphism in CTLA-4 is associated with HT in Asians, but appears to have no effect on HT in Caucasians.
Literature
1.
go back to reference D.S.A. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2), 252–265 (2012)PubMedCrossRef D.S.A. McLeod, D.S. Cooper, The incidence and prevalence of thyroid autoimmunity. Endocrine 42(2), 252–265 (2012)PubMedCrossRef
2.
go back to reference F.K. Kavvoura, T. Akamizu, T. Awata, Y. Ban, D.A. Chistiakov, I. Frydecka, A. Ghaderi, S.C. Gough, Y. Hiromatsu, R. Ploski, P.W. Wang, Y. Ban, T. Bednarczuk, E.I. Chistiakova, M. Chojm, J.M. Heward, H. Hiratani, S.H. Juo, L. Karabon, S. Katayama, S. Kurihara, R.T. Liu, I. Miyake, G.H. Omrani, E. Pawlak, M. Taniyama, T. Tozaki, J.P. Ioannidis, Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J. Clin. Endocrinol. Metab. 92(8), 3162–3170 (2007)PubMedCrossRef F.K. Kavvoura, T. Akamizu, T. Awata, Y. Ban, D.A. Chistiakov, I. Frydecka, A. Ghaderi, S.C. Gough, Y. Hiromatsu, R. Ploski, P.W. Wang, Y. Ban, T. Bednarczuk, E.I. Chistiakova, M. Chojm, J.M. Heward, H. Hiratani, S.H. Juo, L. Karabon, S. Katayama, S. Kurihara, R.T. Liu, I. Miyake, G.H. Omrani, E. Pawlak, M. Taniyama, T. Tozaki, J.P. Ioannidis, Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J. Clin. Endocrinol. Metab. 92(8), 3162–3170 (2007)PubMedCrossRef
3.
go back to reference D. Pastuszak-Lewandoska, E. Sewerynek, D. Domanska, A. Gladys, R. Skrzypczak, E. Brzezianska, CTLA-4 gene polymorphisms and their influence on predisposition to autoimmune thyroid diseases (Graves’ disease and Hashimoto’s thyroiditis). Arch. Med. Sci. 8(3), 415–421 (2012)PubMedCrossRef D. Pastuszak-Lewandoska, E. Sewerynek, D. Domanska, A. Gladys, R. Skrzypczak, E. Brzezianska, CTLA-4 gene polymorphisms and their influence on predisposition to autoimmune thyroid diseases (Graves’ disease and Hashimoto’s thyroiditis). Arch. Med. Sci. 8(3), 415–421 (2012)PubMedCrossRef
4.
go back to reference C. Farra, J. Awwad, A. Fadlallah, G. Sebaly, G. Hage, M. Souaid, H. Ashkar, R. Medlej, M.H. Gannageh, G. Halaby, Genetics of autoimmune thyroid disease in the Lebanese population. J. Community Genet. 3(4), 259–264 (2012)PubMedCrossRef C. Farra, J. Awwad, A. Fadlallah, G. Sebaly, G. Hage, M. Souaid, H. Ashkar, R. Medlej, M.H. Gannageh, G. Halaby, Genetics of autoimmune thyroid disease in the Lebanese population. J. Community Genet. 3(4), 259–264 (2012)PubMedCrossRef
5.
go back to reference J. Yang, Q. Qin, N. Yan, Y.F. Zhu, C. Li, X.J. Yang, X. Wang, M. Pandey, P. Hou, J.A. Zhang, CD40 C/T(-1) and CTLA-4 A/G(49) SNPs are associated with autoimmune thyroid diseases in the Chinese population. Endocrine 41(1), 111–115 (2011)PubMedCrossRef J. Yang, Q. Qin, N. Yan, Y.F. Zhu, C. Li, X.J. Yang, X. Wang, M. Pandey, P. Hou, J.A. Zhang, CD40 C/T(-1) and CTLA-4 A/G(49) SNPs are associated with autoimmune thyroid diseases in the Chinese population. Endocrine 41(1), 111–115 (2011)PubMedCrossRef
6.
go back to reference K. Benhatchi, I. Jochmanova, V. Habalova, H. Wagnerova, I. Lazurova, CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and Hashimoto thyroiditis-results and the review of the literature. Clin. Rheumatol. 30(10), 1319–1324 (2011)PubMedCrossRef K. Benhatchi, I. Jochmanova, V. Habalova, H. Wagnerova, I. Lazurova, CTLA4 exon1 A49G polymorphism in Slovak patients with rheumatoid arthritis and Hashimoto thyroiditis-results and the review of the literature. Clin. Rheumatol. 30(10), 1319–1324 (2011)PubMedCrossRef
7.
go back to reference A.M. Kucharska, E. Gorska, M. Wasik, B. Pyrzak, U. Demkow, Expression of CD152 (CTLA-4) in children with autoimmune thyroiditis and +49 A/G polymorphism of exon 1 of the CTLA-4 gene. J. Physiol. Pharmacol. 60(Suppl 5), 77–80 (2009)PubMed A.M. Kucharska, E. Gorska, M. Wasik, B. Pyrzak, U. Demkow, Expression of CD152 (CTLA-4) in children with autoimmune thyroiditis and +49 A/G polymorphism of exon 1 of the CTLA-4 gene. J. Physiol. Pharmacol. 60(Suppl 5), 77–80 (2009)PubMed
8.
go back to reference A. Bicek, K. Zaletel, S. Gaberscek, E. Pirnat, B. Krhin, T.G. Stopar, S. Hojker, 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease. Hum. Immunol. 70(10), 820–824 (2009)PubMedCrossRef A. Bicek, K. Zaletel, S. Gaberscek, E. Pirnat, B. Krhin, T.G. Stopar, S. Hojker, 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease. Hum. Immunol. 70(10), 820–824 (2009)PubMedCrossRef
9.
go back to reference M. Sahin, A. Gursoy, M.F. Erdogan, Cytotoxic T lymphocyte-associated molecule-4 polymorphism in Turkish patients with Hashimoto thyroiditis. Int. J. Immunogenet. 36(2), 103–106 (2009)PubMedCrossRef M. Sahin, A. Gursoy, M.F. Erdogan, Cytotoxic T lymphocyte-associated molecule-4 polymorphism in Turkish patients with Hashimoto thyroiditis. Int. J. Immunogenet. 36(2), 103–106 (2009)PubMedCrossRef
10.
go back to reference E. Yesilkaya, A. Koc, A. Bideci, O. Camurdan, M. Boyraz, O. Erkal, M.A. Ergun, P. Cinaz, CTLA4 gene polymorphisms in children and adolescents with autoimmune thyroid diseases. Genet. Test 12(3), 461–464 (2008)PubMedCrossRef E. Yesilkaya, A. Koc, A. Bideci, O. Camurdan, M. Boyraz, O. Erkal, M.A. Ergun, P. Cinaz, CTLA4 gene polymorphisms in children and adolescents with autoimmune thyroid diseases. Genet. Test 12(3), 461–464 (2008)PubMedCrossRef
11.
go back to reference Z.Y. Shi, B.Z. Yang, L.B. Wang, R.F. Wu, L.Z. Kang, Study of the A/G (49) polymorphism of CTLA -4 gene exon 1 in autoimmune thyroid diseases. J. ningxia med. univ. 32, 330–333 (2010) Z.Y. Shi, B.Z. Yang, L.B. Wang, R.F. Wu, L.Z. Kang, Study of the A/G (49) polymorphism of CTLA -4 gene exon 1 in autoimmune thyroid diseases. J. ningxia med. univ. 32, 330–333 (2010)
12.
go back to reference S.C. Carleton, The Races of Europe (Greenwood Press, Westport, NewYork, 1939) S.C. Carleton, The Races of Europe (Greenwood Press, Westport, NewYork, 1939)
13.
go back to reference S. Alfadhli, Q. Almutawa, J.M. Abbas, S.A. Doi, Association of Hashimoto’s thyroiditis with cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and inducible co-stimulator (ICOS) genes in a Kuwaiti population. Endocrine 43(3), 666–667 (2012). doi:10.1007/s12020-012-9823-8 PubMedCrossRef S. Alfadhli, Q. Almutawa, J.M. Abbas, S.A. Doi, Association of Hashimoto’s thyroiditis with cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) and inducible co-stimulator (ICOS) genes in a Kuwaiti population. Endocrine 43(3), 666–667 (2012). doi:10.​1007/​s12020-012-9823-8 PubMedCrossRef
14.
go back to reference J. Ying, H.G. Shao, R.W. Pan, P.Z. Li, H.Q. Zhang, X.Y. Zeng, Study on the correlation between CTLA-4, PTPN22 gene polymorphism and Hashimoto’ s thyroiditis in Wenzhou population. J. Wenzhou Med. Coll. 42(4), 346–349 (2012) J. Ying, H.G. Shao, R.W. Pan, P.Z. Li, H.Q. Zhang, X.Y. Zeng, Study on the correlation between CTLA-4, PTPN22 gene polymorphism and Hashimoto’ s thyroiditis in Wenzhou population. J. Wenzhou Med. Coll. 42(4), 346–349 (2012)
15.
go back to reference A.M. Kucharska, A. Wisniewska, K. Popko, U. Demkow, Association between the polymorphism A/G at position 49 of exon 1 of the CTLA-4 gene and antithyroid antibody production in children with Hashimoto’s thyroiditis. Horm. Res. Paediatr. 78(2), 67–72 (2012)PubMedCrossRef A.M. Kucharska, A. Wisniewska, K. Popko, U. Demkow, Association between the polymorphism A/G at position 49 of exon 1 of the CTLA-4 gene and antithyroid antibody production in children with Hashimoto’s thyroiditis. Horm. Res. Paediatr. 78(2), 67–72 (2012)PubMedCrossRef
16.
go back to reference Y.Z. Yu, J.A. Zhang, H.B. Maier, Y. Wang, W.X. Xiao, Y. Quan, B.N. Dong, Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD. Chin. J. cell. mol. immunol. 24(8), 804–807 (2008) Y.Z. Yu, J.A. Zhang, H.B. Maier, Y. Wang, W.X. Xiao, Y. Quan, B.N. Dong, Association of polymorphism of protein tyrosine phosphatase nonreceptor-22 gene with AITD. Chin. J. cell. mol. immunol. 24(8), 804–807 (2008)
17.
go back to reference M. Terauchi, T. Yanagawa, N. Ishikawa, K. Ito, T. Fukazawa, H. Maruyama, T. Saruta, Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto’s thyroiditis in Japanese population. J. Endocrinol. Invest. 26(12), 1208–1212 (2003)PubMed M. Terauchi, T. Yanagawa, N. Ishikawa, K. Ito, T. Fukazawa, H. Maruyama, T. Saruta, Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto’s thyroiditis in Japanese population. J. Endocrinol. Invest. 26(12), 1208–1212 (2003)PubMed
18.
go back to reference T. Tomoyose, I. Komiya, M. Takara, K. Yabiku, Y. Kinjo, Y. Shimajiri, H. Yogi, T. Kouki, M. Masuda, N. Takasu, Cytotoxic T-lymphocyte antigen-4 gene polymorphisms and human T-cell lymphotrophic virus-1 infection: their associations with Hashimoto’s thyroiditis in Japanese patients. Thyroid 12(8), 673–677 (2002)PubMedCrossRef T. Tomoyose, I. Komiya, M. Takara, K. Yabiku, Y. Kinjo, Y. Shimajiri, H. Yogi, T. Kouki, M. Masuda, N. Takasu, Cytotoxic T-lymphocyte antigen-4 gene polymorphisms and human T-cell lymphotrophic virus-1 infection: their associations with Hashimoto’s thyroiditis in Japanese patients. Thyroid 12(8), 673–677 (2002)PubMedCrossRef
19.
go back to reference L. Wang, F. Wang, R.X. Ma, H.W. Yu, Study of the A/G49 polymorphism of CTLA-4 gene exon 1 in autoimmune thyroid diseases. Immunol. J. 17(2), 116–118 (2001) L. Wang, F. Wang, R.X. Ma, H.W. Yu, Study of the A/G49 polymorphism of CTLA-4 gene exon 1 in autoimmune thyroid diseases. Immunol. J. 17(2), 116–118 (2001)
20.
go back to reference A. Petrone, G. Giorgi, C.A. Mesturino, M. Capizzi, I. Cascino, L. Nistico, J. Osborn, U. Di Mario, R. Buzzetti, Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto’s thyroiditis in an Italian population. Thyroid 11(2), 171–175 (2001)PubMedCrossRef A. Petrone, G. Giorgi, C.A. Mesturino, M. Capizzi, I. Cascino, L. Nistico, J. Osborn, U. Di Mario, R. Buzzetti, Association of DRB1*04-DQB1*0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto’s thyroiditis in an Italian population. Thyroid 11(2), 171–175 (2001)PubMedCrossRef
21.
go back to reference Y.J. Park, H.K. Chung, D.J. Park, W.B. Kim, S.W. Kim, J.J. Koh, B.Y. Cho, Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10(6), 453–459 (2000)PubMed Y.J. Park, H.K. Chung, D.J. Park, W.B. Kim, S.W. Kim, J.J. Koh, B.Y. Cho, Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid 10(6), 453–459 (2000)PubMed
22.
go back to reference T. Kouki, Y. Sawai, C.A. Gardine, M.E. Fisfalen, M.L. Alegre, L.J. DeGroot, CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J. Immunol. 165(11), 6606–6611 (2000)PubMed T. Kouki, Y. Sawai, C.A. Gardine, M.E. Fisfalen, M.L. Alegre, L.J. DeGroot, CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves’ disease. J. Immunol. 165(11), 6606–6611 (2000)PubMed
23.
go back to reference T. Awata, S. Kurihara, M. Iitaka, S. Takei, I. Inoue, C. Ishii, K. Negishi, T. Izumida, Y. Yoshida, R. Hagura, N. Kuzuya, Y. Kanazawa, S. Katayama, Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves’ disease and Hashimoto’s thyroiditis) in the Japanese population. Diabetes 47(1), 128–129 (1998)PubMedCrossRef T. Awata, S. Kurihara, M. Iitaka, S. Takei, I. Inoue, C. Ishii, K. Negishi, T. Izumida, Y. Yoshida, R. Hagura, N. Kuzuya, Y. Kanazawa, S. Katayama, Association of CTLA-4 gene A-G polymorphism (IDDM12 locus) with acute-onset and insulin-depleted IDDM as well as autoimmune thyroid disease (Graves’ disease and Hashimoto’s thyroiditis) in the Japanese population. Diabetes 47(1), 128–129 (1998)PubMedCrossRef
24.
go back to reference H. Donner, J. Braun, C. Seidl, H. Rau, R. Finke, M. Ventz, P.G. Walfish, K.H. Usadel, K. Badenhoop, Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto’s thyroiditis and Addison’s disease. J. Clin. Endocrinol. Metab. 82(12), 4130–4132 (1997)PubMedCrossRef H. Donner, J. Braun, C. Seidl, H. Rau, R. Finke, M. Ventz, P.G. Walfish, K.H. Usadel, K. Badenhoop, Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto’s thyroiditis and Addison’s disease. J. Clin. Endocrinol. Metab. 82(12), 4130–4132 (1997)PubMedCrossRef
25.
go back to reference J. Braun, H. Donner, T. Siegmund, P.G. Walfish, K.H. Usadel, K. Badenhoop, CTLA-4 promoter variants in patients with Graves’ disease and Hashimoto’s thyroiditis. Tissue Antigens 51(5), 563–566 (1998)PubMedCrossRef J. Braun, H. Donner, T. Siegmund, P.G. Walfish, K.H. Usadel, K. Badenhoop, CTLA-4 promoter variants in patients with Graves’ disease and Hashimoto’s thyroiditis. Tissue Antigens 51(5), 563–566 (1998)PubMedCrossRef
26.
go back to reference T. Dallos, M. Avbelj, L. Barak, J. Zapletalova, Z. Pribilincova, M. Krajcirova, L. Kostalova, T. Battelino, L. Kovacs, CTLA-4 gene polymorphisms predispose to autoimmune endocrinopathies but not to celiac disease. Neuro. Endocrinol. Lett. 29(3), 334–340 (2008)PubMed T. Dallos, M. Avbelj, L. Barak, J. Zapletalova, Z. Pribilincova, M. Krajcirova, L. Kostalova, T. Battelino, L. Kovacs, CTLA-4 gene polymorphisms predispose to autoimmune endocrinopathies but not to celiac disease. Neuro. Endocrinol. Lett. 29(3), 334–340 (2008)PubMed
Metadata
Title
The CTLA4 +49A/G polymorphism is associated with an increased risk of Hashimoto’s thyroiditis in Asian but not Caucasian populations: an updated meta-analysis
Authors
Ming Feng
Fang-Bin Zhang
Hong-Rong Deng
Publication date
01-10-2013
Publisher
Springer US
Published in
Endocrine / Issue 2/2013
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-013-0014-z

Other articles of this Issue 2/2013

Endocrine 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine